Aaron Kesselheim (2009 Awardee) co-authors "Accelerated Approval and Expensive Drugs — A Challenging Combination" in New England Journal of Medicine, 376, pp. 2001-2004, May 31, 2017, in "Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue" in FiercePharma, May 25, 2017 and in "FDA, EMA and PMDA Seek Antimicrobial Clinical Study Regulation Harmonization" in RAPS, May 26, 2017.
News Source:
Date:
Wednesday, May 31, 2017
Investigator: